MiniMed 780G now integrates with Abbott Instinct continuous glucose monitor, expanding sensor choice, improving flexibility, and advancing interoperability in automated diabetes management systems.

Emerging blood pressure metrics, including variability and vascular aging signals, may help predict dementia risk earlier, enabling proactive prevention through improved monitoring, lifestyle changes, and personalized care strategies.

FDA approved Avlayah for pediatric Hunter syndrome, delivering enzyme therapy across the blood-brain barrier to address neurologic symptoms and improve developmental outcomes in affected children.

State healthcare spending benchmarks alone show limited impact on costs, highlighting need for stronger enforcement, complementary pricing policies, and better data to effectively control hospital prices and premiums.

IOA-244, a selective PI3Kδ inhibitor, shows potential to slow breast cancer by targeting tumor cells and microenvironment, offering safer therapy and biomarker-guided combination strategies.

New cholesterol guidelines emphasize earlier screening, personalized risk assessment, and aggressive LDL reduction, incorporating genetic factors like lipoprotein(a) to improve prevention, while raising cost, access, and overdiagnosis concerns.

Psilocybin-assisted therapy shows promise for treatment-resistant mental disorders, but widespread adoption depends on resolving safety, training, regulatory, and access challenges while ensuring durable, equitable patient outcomes.

Medicare Shared Savings Program shows net savings over a decade, but results vary, highlighting benefits of value-based care alongside concerns about costs, equity, and program design.

Ketamine-assisted psychotherapy combined with mindfulness-based MORE shows promise for opioid use disorder by reducing cravings and improving regulation, but raises safety, training, and access challenges.

Catheter-based aspiration offers a less invasive option for right-sided infective endocarditis, enabling vegetation removal and infection control in high-risk patients while requiring careful selection and multidisciplinary management.